Search for: "PFIZER PHARMACEUTICALS"
Results 1 - 20
of 1,413
Sort by Relevance
|
Sort by Date
9 May 2024, 10:55 am
Conclusion: The settlement of over 10,000 Zantac lawsuits by Pfizer marks a significant step in the ongoing battle for accountability in pharmaceutical safety. [read post]
1 May 2024, 1:18 pm
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
29 Apr 2024, 4:15 am
The COVID-19 vaccine was quickly rolled out compared to other vaccines in the past and many pharmaceutical companies benefited financially. [read post]
29 Apr 2024, 4:15 am
The COVID-19 vaccine was quickly rolled out compared to other vaccines in the past and many pharmaceutical companies benefited financially. [read post]
18 Mar 2024, 6:27 am
Pfizer, the pharmaceutical company, has a fellowship program that seeks to advance students and "early career colleagues of Black/American, Latino/Hispanic and Native American descent. [read post]
17 Mar 2024, 2:00 am
Miroslava Marinova (University of East London), Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications (2023): The legal treatment of excessive pricing in the pharmaceutical sector has been a... [read post]
13 Mar 2024, 7:24 pm
§ 1.750, applicant is required to submit the following to the Office: Evidence that Opko Biologics Ltd. is expressly authorized to rely upon the regulatory review activities by Pfizer Ireland Pharmaceuticals (Pfizer), the marketing applicant before the Food and Drug Administration to support the application for patent term extension of U.S. [read post]
31 Jan 2024, 7:30 am
The decision comes after a federal appeals court in New York rejected a similar challenge to HHS OIG made by pharmaceutical giant Pfizer. [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
28 Dec 2023, 12:56 pm
Pfizer then made “donations” to the foundation to cover the copays. [read post]
22 Dec 2023, 12:00 am
Evidence of overlooked protocols aids negligence arguments against possibly careless doctors and pharmaceutical accountability reasons. [read post]
20 Dec 2023, 5:00 am
Sanofi will affect innovation and the pharmaceutical industry. [read post]
12 Dec 2023, 5:00 am
The disclosure of the records, and subsequent analysis thereof led by the HJI have revealed that not only was South Africa charged more for COVID-19 vaccines than countries in the Global North, but also that the terms and conditions that the state had to agree to were overwhelmingly one-sided, favouring multinational pharmaceutical companies (including Janssen Pharmaceuticals, which produces the J&J vaccine, as well as with Pfizer, and the Serum Institute of… [read post]
6 Dec 2023, 11:25 am
Panuwat had learned from Medivation’s CEO that the company expected to be acquired by a major pharmaceutical company, Pfizer, within a few days, at a premium to the then-market price. [read post]
29 Nov 2023, 5:00 am
After an iconic ad campaign, Pfizer’s iconic little blue pills had the quickest sales growth in pharmaceutical history. [read post]
21 Nov 2023, 12:53 pm
Release: Pharmaceutical Research and Manufacturers of America — the trade association also known as PhRMA that represents the country’s top drug companies, including Eli Lilly, Merck, and Pfizer — has contributed more than $34.5 million to the Republican-aligned dark money… Continue reading The post “PhRMA contributed record sum to GOP-aligned dark money group in 2022, new tax filing reviewed by Issue One shows” appeared first on Election Law… [read post]
21 Nov 2023, 4:44 am
Today, companies like Merck, Pfizer, Novartis, BMS, GSK, and others have reputations for quality. [read post]
3 Oct 2023, 9:50 am
Compensation for plaintiffs in the litigation now totals $533.5 million, including additional settlements with GlaxoSmithKline, Pfizer, and Procter & Gamble. [read post]
27 Sep 2023, 7:15 pm
In all, according to our estimates, 75 percent of the benefits of striking down the MRT would go to just three sectors: tech, pharmaceuticals, and finance. [read post]
12 Sep 2023, 9:42 am
Pharmaceutical startups and those in the tech industry have been among those most reported. [read post]